APA (7th ed.) Citation

Greenberg, R. N., Hay, C. M., Stapleton, J. T., Marbury, T. C., Wagner, E., Kreitmeir, E., . . . Chaplin, P. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PloS one, 11(6), e0157335. https://doi.org/10.1371/journal.pone.0157335

Chicago Style (17th ed.) Citation

Greenberg, Richard N., et al. "A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects." PloS One 11, no. 6 (2016): e0157335. https://doi.org/10.1371/journal.pone.0157335.

MLA (9th ed.) Citation

Greenberg, Richard N., et al. "A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects." PloS One, vol. 11, no. 6, 2016, p. e0157335, https://doi.org/10.1371/journal.pone.0157335.